Models and analyses to understand threats to polio eradication
- PMID: 29268738
- PMCID: PMC5740775
- DOI: 10.1186/s12916-017-0991-5
Models and analyses to understand threats to polio eradication
Abstract
To achieve complete polio eradication, the live oral poliovirus vaccine (OPV) currently used must be phased out after the end of wild poliovirus transmission. However, poorly understood threats may arise when OPV use is stopped. To counter these threats, better models than those currently available are needed. Two articles recently published in BMC Medicine address these issues. Mercer et al. (BMC Med 15:180, 2017) developed a statistical model analysis of polio case data and characteristics of cases occurring in several districts in Pakistan to inform resource allocation decisions. Nevertheless, despite having the potential to accelerate the elimination of polio cases, their analyses are unlikely to advance our understanding OPV cessation threats. McCarthy et al. (BMC Med 15:175, 2017) explored one such threat, namely the emergence and transmission of serotype 2 circulating vaccine derived poliovirus (cVDPV2) after OPV2 cessation, and found that the risk of persistent spread of cVDPV2 to new areas increases rapidly 1-5 years after OPV2 cessation. Thus, recently developed models and analysis methods have the potential to guide the required steps to surpass these threats. 'Big data' scientists could help with this; however, datasets covering all eradication efforts should be made readily available.Please see related articles: https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0937-y and https://bmcmedicine.biomedcentral.com/articles/10.1186/s12916-017-0941-2 .
Keywords: Complex system inference; Dynamic system analysis; Inference robustness assessment; POMP; Polio eradication; Polio transmission models.
Conflict of interest statement
Authors’ information
The author has had a 44-year career dedicated to public health and disease surveillance and since 1978 has dedicated his career, as a professor at the University of Michigan, to developing theory that serves public health. Since 1986 that has been involved with advancing both methodological and practical methods for models of the type reviewed herein.
Competing interests
The author declares that he has no competing interests.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Comment on
-
The risk of type 2 oral polio vaccine use in post-cessation outbreak response.BMC Med. 2017 Oct 4;15(1):175. doi: 10.1186/s12916-017-0937-y. BMC Med. 2017. PMID: 28974220 Free PMC article.
-
Spatial model for risk prediction and sub-national prioritization to aid poliovirus eradication in Pakistan.BMC Med. 2017 Oct 11;15(1):180. doi: 10.1186/s12916-017-0941-2. BMC Med. 2017. PMID: 29017491 Free PMC article.
References
-
- WHO: WHO Global Action Plan to minimize poliovirus facility-associated risk (GAPIII). In. Edited by Organization WH. Geneva: WHO; 2015.
-
- GPEI: Global Polio Eradication Initiative Annual Report 2016. In: Polio Eradication. http://polioeradication.org/wp-content/uploads/2017/08/AR2016_EN.pdf: WHO; 2016. Accessed 14 Dec 2017.
-
- GPEI: Circulating vaccine-derived poliovirus. In: Polio Eradication. http://polioeradication.org/polio-today/polio-now/this-week/circulating-...: WHO; 2017: Table of cVDPV cases per year. Accessed 14 Dec 2017.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
